Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-18-042912
Filing Date
2018-06-28
Accepted
2018-06-28 17:18:29
Documents
1
Group Members
SAGARD CAPITAL PARTNERS GP, INC.SAGARD CAPITAL PARTNERS MANAGEMENT CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a18-16210_1sc13da.htm SC 13D/A 334903
  Complete submission text file 0001104659-18-042912.txt   336596
Mailing Address 280 PARK AVENUE, 3RD FLOOR WEST NEW YORK NY 10017
Business Address 280 PARK AVENUE, 3RD FLOOR WEST NEW YORK NY 10017 203 629-6700
Sagard Capital Partners, L.P. (Filed by) CIK: 0001423385 (see all company filings)

EIN.: 203332164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Subject) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88872 | Film No.: 18926337
SIC: 2834 Pharmaceutical Preparations